4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0000935836-25-000396
Chief Clinical Officer acquired 57,380 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Langsam Jeffrey · Chief Clinical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-05-21 | Grant or award : show line 1 in the form | +57,380 | 57,380 | D |
Loading xslF345X05/ownership.xml…